Analyst firms · Evercore ISI · EW

Evercore ISI EW price target and rating history

Edwards Lifesciences Corporation (EW) · Health Care

Evercore ISI rates Edwards Lifesciences Corporation (EW) Outperform with a $88 price target, as of its latest action on Oct 7, 2025. It has published 3 rating actions on EW since January 2022, including 1 upgrade and 1 downgrade. Across 7 firms with a EW price target in the last 12 months, the median target is $110.

Current rating
Outperform
Price target
$88
Median target, all firms
$110
Actions on EW
3

Evercore ISI price target on EW

$122$100$772023202420252026
Evercore ISI price target on EW, each point a stated target, January 2022 to October 2025.

Every Evercore ISI rating on EW

How other firms rate EW

Each firm's latest rating and stated target in the last 12 months.

FirmRatingPrice targetDate
Robert W. BairdOutperform$116Nov 5, 2026
Truist SecuritiesBuy$113Nov 4, 2026
BarclaysOverweight$110Oct 7, 2026
UBSBuy$110Jul 28, 2026
Leerink PartnersOutperform$101Jul 24, 2026
Wolfe ResearchOutperform$92Apr 1, 2026
TD CowenBuy$97Jan 9, 2026

Questions about Evercore ISI and EW

What is Evercore ISI's price target for EW?
Evercore ISI's latest stated price target for Edwards Lifesciences Corporation (EW) is $88, from its action on Oct 7, 2025.
What is Evercore ISI's rating on EW?
Evercore ISI rates EW Outperform, a bullish rating, as of Oct 7, 2025.
When did Evercore ISI last change its view on EW?
On Oct 7, 2025, Evercore ISI upgrades to Outperform from In-line, price target $88.
How does Evercore ISI's EW target compare with other analysts?
Across 7 firms with a EW price target in the last 12 months, the median target is $110.

More EW rating histories

All Evercore ISI ratingsEW news and filingsEvery analyst firm

From rating actions in the Quantisnow feed. A target holds until the firm states a new one; a reiteration with no target keeps the last one. Not investment advice.